Project lifeline: implementing SBIRT in rural pharmacies to address opioid overdoses and substance use disorder

References

• [accessed 2019 December17]. www.cdc.gov/drugoverdose/training/oud/accessible/index.html
   Google Scholar
• Center for Behavioral Health Statistics and Quality. National Survey on Drug Use and Health: detailed Tables. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2017.
   Google Scholar
• American Psychiatric Association. American Psychiatric Association: diagnostic and Statistical Manual of Mental Disorders: diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington (VA): American Psychiatric Association; 2013.
   Google Scholar
• Webster LR. Risk factors for opioid-use disorder and overdose. Anesthesia Analgesia. 2017;125:1741–48. doi:10.1213/ANE.0000000000002496
   PubMed Web of Science ®Google Scholar
• Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths—United States, 2013–2017. Morb Mort Wkly Rep. 2019;67:1419. doi:10.15585/mmwr.mm675152e1
   Web of Science ®Google Scholar
• Wilson N, Kariisa M, Seth P, Smith H IV, Davis NL. Drug and opioid-involved overdose deaths — United States, 2017–2018. MMWR Morb Mortal Wkly Rep. 2020;69:290–97. doi:10.15585/mmwr.mm6911a4
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention National Center for Health Statistics. Multiple causes of death 1999-2017: cDC Wonder online database. Atlanta, GA, USA: National Center for Health Statistics; 2018.
   Google Scholar
• [accessed 2021 November 18]. www.cdc.gov/drugoverdose/deaths/2018.html
   Google Scholar
• [accessed 2019 December 17]. www.overdosefreepa.pitt.edu/wp-content/uploads/2019/10/Drug-Related-Overdose-Deaths-in-Pennsylvania-2018.pdf
   Google Scholar
• [accessed 2022 October13]. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/202205.htm#:~:text=The%20new%20data%20show%20overdose,in%202021%20compared%20to%202020
   Google Scholar
• Bernstein SL, D’onofrio G. A promising approach for emergency departments to care for patients with substance use and behavioral disorders. Health Aff. 2013;32:2122–28. doi:10.1377/hlthaff.2013.0664
   PubMed Web of Science ®Google Scholar
• Donovan DM, Bogenschutz MP, Perl H, Forcehimes A, Adinoff B, Mandler R, Oden N, Walker R. Study design to examine the potential role of assessment reactivity in the Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) protocol. Addict Sci Clin Pract. 2012;7:16. doi:10.1186/1940-0640-7-16
   PubMedGoogle Scholar
• Centers for Medicare Services. Screening, Brief Intervention, and Referral to Treatment (SBIRT) services. Netherlands: Elsevier and Amsterdam. 2019.
   Google Scholar
• Richter KP, Faseru B, Shireman TI, Mussulman LM, Nazir N, Bush T, Scheuermann TS, Preacher KJ, Carlini BH, Magnusson B, et al. Warm handoff versus fax referral for linking hospitalized smokers to quitlines. Am J Prev Med. 2016;51:587–96. doi:10.1016/j.amepre.2016.04.006
   PubMed Web of Science ®Google Scholar
• Williams AR, Nunes EV, Bisaga A, Levin FR, Olfson M. Development of a cascade of care for responding to the opioid epidemic. Am J Drug Alcohol Abuse. 2019;45:1–10. doi:10.1080/00952990.2018.1546862
   PubMed Web of Science ®Google Scholar
• Wamsley M, Satterfield JM, Curtis A, Lundgren L, Satre DD. Alcohol and Drug Screening, Brief Intervention, and Referral to Treatment (SBIRT) training and implementation: perspectives from 4 health professions. J Addict Med. 2018;12:262–72. doi:10.1097/ADM.0000000000000410
   PubMed Web of Science ®Google Scholar
• Codell N, Kelley AT, Jones AL, Dungan MT, Valentino N, Holtey AI, Knight TJ, Butz A, Gallop C, Erickson S. Aims, development, and early results of an interdisciplinary primary care initiative to address patient vulnerabilities. Am J Drug Alcohol Abuse. 2021;47:160–69. doi:10.1080/00952990.2020.1832507
   PubMed Web of Science ®Google Scholar
• Hankin A, Daugherty M, Bethea A, Haley L. The emergency department as a prevention site: a demographic analysis of substance use among ED patients. Drug Alcohol Depend. 2013;130:230–33. doi:10.1016/j.drugalcdep.2012.10.027
   PubMed Web of Science ®Google Scholar
• Pringle JL, Kelley DK, Kearney SM, Aldridge A, Dowd W, Johnjulio W, Venkat A, Madden M, Lovelace J. Screening, brief intervention, and referral to treatment in the emergency department: an examination of health care utilization and costs. Med Care. 2018;56:146–52. doi:10.1097/MLR.0000000000000859
   PubMed Web of Science ®Google Scholar
• Gustafson A, Hankins S, Jilcott S. Measures of the consumer food store environment: a systematic review of the evidence 2000-2011. J Community Health. 2012;37:897–911. doi:10.1007/s10900-011-9524-x
   PubMed Web of Science ®Google Scholar
• Pringle JL, Melczak M, Johnjulio W, Campopiano M, Gordon AJ, Costlow M. Pennsylvania SBIRT medical and residency training: developing, implementing, and evaluating an evidenced-based program. Substance Abuse. 2012;33:292–97. doi:10.1080/08897077.2011.640091
   PubMed Web of Science ®Google Scholar
• Ghosh A, Sharma K. Screening and brief intervention for substance use disorders in times of COVID-19: potential opportunities, adaptations, and challenges. Am J Drug Alcohol Abuse. 2021;47:154–59. doi:10.1080/00952990.2020.1865996
   PubMed Web of Science ®Google Scholar
• [accessed 2019 December 17]. www.apha.org/policies-and-advocacy/public-health-policy-statements/policy-database/2014/07/07/13/05/the-role-of-the-pharmacist-in-public-health
   Google Scholar
• Pringle JC, Aruru M, Aruru M. Role of pharmacists in the opioid use disorder (OUD) crisis. Res Soc Administrative Policy. 2019;15:28–29. doi:10.1016/j.sapharm.2018.11.005
   Web of Science ®Google Scholar
• [accessed 2022 October13]. https://www.blairdap.org/about/history/
   Google Scholar
• [accessed 2022 October13]. https://www.census.gov/quickfacts/fact/table/blaircountypennsylvania/PST045221
   Google Scholar
• Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. Primary care validation of a single-question alcohol screening test. J Gen Intern Med. 2009;24:783–88. doi:10.1007/s11606-009-0928-6
   PubMed Web of Science ®Google Scholar
• Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med. 2010;170:1155–60. doi:10.1001/archinternmed.2010.140
   PubMed Web of Science ®Google Scholar
• Scott KA, Pringle J. The power of the frame: systems transformation framework for health care leaders. Nurs Adm Q. 2018;42:4–14. doi:10.1097/NAQ.0000000000000261
   PubMedGoogle Scholar
• Aldridge RW, Story A, Hwang SW, Nordentoft M, Luchenski SA, Hartwell G, Tweed EJ, Lewer D, Vittal Katikireddi S, Hayward AC. Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis. Lancet. 2018;391:241–50. doi:10.1016/S0140-6736(17)31869-X
   PubMed Web of Science ®Google Scholar
• Pringle JL, Boyer A, Conklin MH, McCullough JW, Aldridge A. The Pennsylvania project: pharmacist intervention improved medication adherence and reduced health care costs. Health Aff (Millwood). 2014;33:1444–52. doi:10.1377/hlthaff.2013.1398
   PubMed Web of Science ®Google Scholar
• Bacci JL, McGrath SH, Pringle JL, Maguire MA, McGivney MS. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: the Pennsylvania project. J Am Pharm Assoc. (2003) 2014;54:584–93. doi:10.1331/JAPhA.2014.14034.
   Google Scholar
• Miech EJ, Rattray NA, Flanagan ME, Damschroder L, Schmid AA, Damush TM. Inside help: an integrative review of champions in healthcare-related implementation. SAGE Open Med. 2018;6:2050312118773261. doi:10.1177/2050312118773261.
   Web of Science ®Google Scholar
• Higgins-Biddle JC, Babor TF. A review of the Alcohol Use Disorders Identification Test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: past issues and future directions. Am J Drug Alcohol Abuse. 2018;44:578–86. doi:10.1080/00952990.2018.1456545
   PubMed Web of Science ®Google Scholar
• Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the drug abuse screening test. J Subst Abuse Treat. 2007;32:189–98. doi:10.1016/j.jsat.2006.08.002
   PubMed Web of Science ®Google Scholar
• Maisto SA, Carey MP, Carey KB, Gordon CM, Gleason JR. Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness. Psychol Assess. 2000;12:186. doi:10.1037/1040-3590.12.2.186
   PubMed Web of Science ®Google Scholar
• Babor T, Higgins-biddle J, Robaina K. The alcohol use disorders identification test, adapted for use in the United States: a guide for primary care practitioners. In: Monteiro M, ed. AUDIT: The Alcohol Use Disorders Identification Test Guidelines for Use in Primary Care. Geneva, Switzerland: Substance Abuse Mental Health Services Administration/Center for Substance Abuse Treatment; 2016:14–20 .
   Google Scholar
• [accessed 2022 June22]. www.census.gov/quickfacts/fact/dashboard/blaircountypennsylvania
   Google Scholar
• Hagemeier NE, Alamian A, Murawski MM, Pack RP. Factors associated with provision of addiction treatment information by community pharmacists. J Subst Abuse Treat. 2015;52:67–72. doi:10.1016/j.jsat.2014.11.006.
   PubMed Web of Science ®Google Scholar
• Monteiro K, Dumenco L, Collins S, Bratberg J, MacDonnell C, Jacobson A, Dollase R, George P. An interprofessional education workshop to develop health professional student opioid misuse knowledge, attitudes, and skills. J Am Pharm Assoc. (2003) 2017;57:S113–s117. doi:10.1016/j.japh.2016.12.069.
   Google Scholar
• Nielsen S, Kowalski M, Wood P, Larney S, Bruno R, Shanahan M, Lenton S, Dietze P, Green T, Murnion B, et al. Routine opioid outcome monitoring in community pharmacy: pilot implementation study protocol. Res Social Adm Pharm. 2019;15:1047–55. doi:10.1016/j.sapharm.2018.10.024
   PubMedGoogle Scholar
• Cochran GT, Engel RJ, Hruschak VJ, Tarter RE. Prescription opioid misuse among rural community pharmacy patients: pilot study for screening and implications for future practice and research. J Pharm Pract. 2017;30:498–505. doi:10.1177/0897190016656673
   PubMedGoogle Scholar
• Shonesy BC, Williams D, Simmons D, Dorval E, Gitlow S, Gustin RM. Screening, brief intervention, and referral to treatment in a retail pharmacy setting: the pharmacist’s role in identifying and addressing risk of substance use disorder. J Addict Med. 2019;13:403–07. doi:10.1097/ADM.0000000000000525
   PubMed Web of Science ®Google Scholar
• Waye KM, Goyer J, Dettor D, Mahoney L, Samuels EA, Yedinak JL, Marshall BDL. Implementing peer recovery services for overdose prevention in Rhode Island: an examination of two outreach-based approaches. Addict Behav. 2019;89:85–91. doi:10.1016/j.addbeh.2018.09.027.
   PubMed Web of Science ®Google Scholar
• Chou R, Korthuis PT, McCarty D, Coffin P, Griffin J, Davis-O’reilly C, Grusing S, Daya M. AHRQ comparative effectiveness reviews. In: Chou R, ed. Management of suspected opioid overdose with naloxone by emergency medical services personnel. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017:EHCO25-EF.
   Google Scholar
• Crawford ND, Amesty S, Rivera AV, Harripersaud K, Turner A, Fuller CM. Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City. Am J Public Health. 2013;103:1579–82. doi:10.2105/AJPH.2012.301178
   PubMed Web of Science ®Google Scholar
• Oramasionwu CU, Johnson TL, Zule WA, Carda-Auten J, Golin CE. Using pharmacies in a structural intervention to distribute low dead space syringes to reduce HIV and HCV transmission in people who inject drugs. Am J Public Health. 2015;105:1066–71. doi:10.2105/AJPH.2015.302581
   PubMed Web of Science ®Google Scholar
• Contreras J, Baus C, Brandt C, Witry M, Peters J, Evoy KE. Pharmacist counseling when dispensing naloxone by standing order: a secret shopper study of 4 chain pharmacies. J Am Pharm Assoc. 2021;61:e94–99. doi:10.1016/j.japh.2020.10.010
   Google Scholar
• Santa HM, Amirova SG, Ventricelli DJ, Downs GE, Nowalk AA, Pringle JL, Aruru M. Preparing pharmacists to increase naloxone dispensing within community pharmacies under the Pennsylvania standing order. Am J Health Sys Pharm. 2020;78:327–35. doi:10.1093/ajhp/zxaa387
   Web of Science ®Google Scholar
• Hammer GP, du Prel JB, Blettner M. Avoiding bias in observational studies: part 8 in a series of articles on evaluation of scientific publications. Dtsch Arztebl Int. 2009;106:664–68. doi:10.3238/arztebl.2009.0664
   PubMed Web of Science ®Google Scholar
• Jepsen P, Johnsen SP, Gillman MW, Sørensen HT. Interpretation of observational studies. Heart. 2004;90:956–60. doi:10.1136/hrt.2003.017269
   PubMed Web of Science ®Google Scholar